Extended Research Article
The Age of BLood Evaluation (ABLE) randomised controlled trial: description of the UK-funded arm of the international trial, the UK cost-utility analysis and secondary analyses exploring factors associated with health-related quality of life and health-care costs during the 12-month follow-up
Timothy S Walsh
,
Simon Stanworth
,
Julia Boyd
,
David Hope
,
Sue Hemmatapour
,
Helen Burrows
et al.
-
Journal:
Health Technology Assessment Volume: 21, Issue: 62
-
Published:
25 October 2017